PET scans to assess response to chemotherapy for esophageal cancer
Filed under: Chemotherapy, Esophageal Cancer, Research
At a meeting of the Society of Nuclear Medicine in Washington in early June, German scientists reported that imaging with positron emission tomography (PET) can show esophageal cancer patients’ responses to chemotherapy.
“This is the first study to apply PET results from early metabolic response assessment to clinical decision making in the treatment of common solid tumors, said Ken Herrmann of the Technical University in Munich, Germany. “The outcome for metabolic responders turned out to be remarkably favorable compared to metabolic non-responders.”
According to Herrmann, the results can help select patients who are benefiting from chemotherapy and “circumvent the adminstration of inefficient chemotherapy to patients with no metabolic response.”
Read | Permalink | Email this | Linking Blogs | Comments
Original post by Patricia Mayville-Cox
No comments yet. Be the first.
Leave a reply
PET scans to assess response to chemotherapy for esophageal cancer
Filed under: Chemotherapy, Esophageal Cancer, Research
At a meeting of the Society of Nuclear Medicine in Washington in early June, German scientists reported that imaging with positron emission tomography (PET) can show esophageal cancer patients’ responses to chemotherapy.
“This is the first study to apply PET results from early metabolic response assessment to clinical decision making in the treatment of common solid tumors, said Ken Herrmann of the Technical University in Munich, Germany. “The outcome for metabolic responders turned out to be remarkably favorable compared to metabolic non-responders.”
According to Herrmann, the results can help select patients who are benefiting from chemotherapy and “circumvent the adminstration of inefficient chemotherapy to patients with no metabolic response.”
Read | Permalink | Email this | Linking Blogs | Comments
Original post by Patricia Mayville-Cox
No comments yet. Be the first.
Leave a reply